These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9784511)

  • 1. Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection.
    Penttilä JM; Anttila M; Puolakkainen M; Laurila A; Varkila K; Sarvas M; Mäkelä PH; Rautonen N
    Infect Immun; 1998 Nov; 66(11):5113-8. PubMed ID: 9784511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection.
    Geng Y; Berencsi K; Gyulai Z; Valyi-Nagy T; Gonczol E; Trinchieri G
    Infect Immun; 2000 Apr; 68(4):2245-53. PubMed ID: 10722626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice.
    Penttilä JM; Anttila M; Varkila K; Puolakkainen M; Sarvas M; Mäkelä PH; Rautonen N
    Immunology; 1999 Jul; 97(3):490-6. PubMed ID: 10447772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.
    Vuola JM; Puurula V; Anttila M; Mäkelä PH; Rautonen N
    Infect Immun; 2000 Feb; 68(2):960-4. PubMed ID: 10639472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen.
    Wizel B; Starcher BC; Samten B; Chroneos Z; Barnes PF; Dzuris J; Higashimoto Y; Appella E; Sette A
    J Immunol; 2002 Sep; 169(5):2524-35. PubMed ID: 12193722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of a novel pulmonary CD3(-) CD4(+) CD8(+) cell population in mice during Chlamydia pneumoniae infection.
    Penttilä JM; Pyhälä R; Sarvas M; Rautonen N
    Infect Immun; 1998 Jul; 66(7):3290-4. PubMed ID: 9632597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity.
    Lu H; Yang X; Takeda K; Zhang D; Fan Y; Luo M; Shen C; Wang S; Akira S; Brunham RC
    Mol Med; 2000 Jul; 6(7):604-12. PubMed ID: 10997341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression signatures characterizing the development of lymphocyte response during experimental Chlamydia pneumoniae infection.
    Kyläniemi MK; Haveri A; Vuola JM; Puolakkainen M; Lahesmaa R
    Microb Pathog; 2009 May; 46(5):235-42. PubMed ID: 19486640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective DNA immunization against Chlamydia pneumoniae.
    Svanholm C; Bandholtz L; Castaños-Velez E; Wigzell H; Rottenberg ME
    Scand J Immunol; 2000 Apr; 51(4):345-53. PubMed ID: 10736106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice.
    Rottenberg ME; Gigliotti Rothfuchs AC; Gigliotti D; Svanholm C; Bandholtz L; Wigzell H
    J Immunol; 1999 Mar; 162(5):2829-36. PubMed ID: 10072530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.
    Johansson M; Schön K; Ward M; Lycke N
    Infect Immun; 1997 Mar; 65(3):1032-44. PubMed ID: 9038313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model.
    Erkkilä L; Saario E; Laitinen K; Saikku P; Leinonen M
    Vaccine; 2008 May; 26(20):2503-9. PubMed ID: 18433949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization.
    Kaukoranta-Tolvanen SE; Laurila AL; Saikku P; Leinonen M; Laitinen K
    Microb Pathog; 1995 Apr; 18(4):279-88. PubMed ID: 7476093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmacytoid dendritic cells mediate the regulation of inflammatory type T cell response for optimal immunity against respiratory Chlamydia pneumoniae infection.
    Joyee AG; Yang X
    PLoS One; 2013; 8(12):e83463. PubMed ID: 24386207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice.
    Jupelli M; Guentzel MN; Meier PA; Zhong G; Murthy AK; Arulanandam BP
    J Immunol; 2008 Mar; 180(6):4148-55. PubMed ID: 18322226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue.
    Huang J; Wang MD; Lenz S; Gao D; Kaltenboeck B
    J Immunol; 1999 Feb; 162(4):2217-26. PubMed ID: 9973497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT1 regulates IFN-alpha beta- and IFN-gamma-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells.
    Rothfuchs AG; Trumstedt C; Mattei F; Schiavoni G; Hidmark A; Wigzell H; Rottenberg ME
    J Immunol; 2006 Jun; 176(11):6982-90. PubMed ID: 16709859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma.
    Rothfuchs AG; Kreuger MR; Wigzell H; Rottenberg ME
    J Immunol; 2004 Feb; 172(4):2407-15. PubMed ID: 14764711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
    Marks E; Verolin M; Stensson A; Lycke N
    Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.